Evaluation of dithiol chelating agents as potential adjuvants for anti-IL-2 receptor lead or bismuth alpha radioimmunotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/8868281

Download in:

View as

General Info

PMID
8868281